Pharma Journalist -

Marken announced the acquisition of PCX International Co. Ltd based in Japan. PCX operates from their Tokyo headquarters to coordinate the delivery of over 3,000 clinical trial…
Read More...

Pfenex Inc. and Arcellx, Inc. announced a Development, Evaluation and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to…
Read More...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative…
Read More...

Cambrex Corporation announced that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland, doubling the current footprint to…
Read More...

NeoGenomics, Inc. and Pharmaceutical Product Development, LLC (PPD) announced the grand opening of a NeoGenomics oncology-focused clinical trials testing lab in the same building as the…
Read More...

Novartis announced Kisqali (ribociclib) achieved statistically significant improvement in overall survival in the Phase III MONALEESA-3 clinical trial. This is the second Phase III…
Read More...

Alligator Bioscience announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013…
Read More...

Exelixis, Inc. announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited (Aurigene), the India-based…
Read More...

SMi Reports: SMi has released an exclusive interview with industry expert Dr Sigbjorn Gregusson, Managing Director, BioBank AS ahead of the upcoming Biobanking conference this September…
Read More...

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced that Alvotech and…
Read More...